SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      under
                           THE SECURITIES ACT OF 1933
                             HAEMONETICS CORPORATION
               (Exact name of issuer as specified in its charter)

                            Massachusetts 04-2882273
          (State of Incorporation) (IRS Employer Identification Number)

          400 Wood Road, Braintree, Massachusetts 02814 (617) 848-7100
          -------------------------------------------------------------
          (Address and telephone number of Principal Executive Offices)

                             HAEMONETICS CORPORATION

                        1998 Employee Stock Purchase Plan
                            (Full title of the Plan)

                        Alicia R. Lopez, General Counsel
                             Haemonetics Corporation
                                  400 Wood Road
                         Braintree, Massachusetts 02184
                                 (617) 848-7100

              (Name, address and telephone number of agent service)

                                    Copy to:
                                Mary Ellen O'Mara
                           Hutchins, Wheeler & Dittmar
                           A Professional Corporation
                               101 Federal Street
                           Boston, Massachusetts 02110

                         CALCULATION OF REGISTRATION FEE



                                                 Proposed                Proposed
                                                 Maximum                 Maximum
Title of                 Amount                  Offering                Aggregate                Amount of
Securities               to be                   Price                   Offering                 Registration
to be Registered         Registered(1)           Per Share                   Price                     Fee(2)
- ----------------         -------------           ---------               ------------             -----------
                                                                                           
Common Stock,             375,000                 $15.59                 $5,846,250                 $1,725
par value
$.01 per share

(1) Also registered hereunder are such additional number of shares of Common Stock, presently indeterminable, as may be necessary to satisfy the antidilution provisions of the Plan to which this Registration Statement relates. (2) The registration fee has been calculated on the basis of the average of the high and low sale prices on the New York Stock Exchange on August 11, 1998. PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3. Incorporation of Documents by Reference The Company hereby incorporates by reference the documents listed in (a) through (c) below. In addition, all documents subsequently filed by the Company pursuant to Section 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 (prior to the filing of a Post-Effective Amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold) shall be deemed to be incorporated by reference in this Registration Statement and to be a part thereof from the date of filing of such documents. (a) The Company's latest annual report filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 or the latest Prospectus filed pursuant to Rule 424(b) under the Securities Act of 1933, which contains either directly or by incorporation by reference audited financial statements for the Company's latest fiscal year for which such statements have been filed. (b) All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 since the end of the fiscal year covered by the annual report or the Prospectus referred to in (a) above. (c) The description of the Company's Common Stock which is contained in the Registration Statement filed by the Company under the Securities Exchange Act of 1934, including any amendment or report filed for the purpose of updating such description. Item 4. Description of Securities Inapplicable Item 5. Interests of Named Experts and Counsel The financial statements and schedules incorporated by reference in this Registration Statement have been audited by Arthur Andersen LLP, independent public accountants, as indicated in their reports with respect thereto, and are incorporated by reference herein in reliance upon the authority of said firm as experts in giving said reports. The validity of the authorization and issuance of the Common Stock offered hereby will be passed upon for the Company by Hutchins, Wheeler & Dittmar, a Professional Corporation, Boston, Massachusetts. Item 6. Indemnification of Directors and Officers Section 67 of Chapter 156B of the General Laws of the Commonwealth of Massachusetts provides as follows: - 2 - "Section 67. Indemnification of directors, officers, employees and other agents of a corporation, and persons who serve at its request as directors, officers, employees or other agents of another organization, or who serve at its request in any capacity with respect to any employee benefit plan, may be provided by it to whatever extent shall be specified in or authorized by (i) the articles of organization or (ii) a by-law adopted by the stockholders or (iii) a vote adopted by the holders of a majority of the shares of stock entitled to vote on the election of directors. Except as the articles of organization or by-laws otherwise require, indemnification of any persons referred to in the preceding sentence who are not directors of the corporation may be provided by it to the extent authorized by the directors. Such indemnification may include payment by the corporation of expenses incurred in defending a civil or criminal action or proceeding in advance of the final disposition of such action or proceeding, upon receipt of an undertaking by the person indemnified to repay such payment if he shall be adjudicated to be not entitled to indemnification under this section which undertaking may be accepted without reference to the financial ability of such person to make repayment. Any such indemnification may be provided although the person to be indemnified is no longer an officer, director, employee or agent of the corporation or of such other organization or no longer serves with respect to any such employee benefit plan. No indemnification shall be provided for any person with respect to any matter as to which he shall have been adjudicated in any proceeding not to have acted in good faith in the reasonable belief that his action was in the best interest of the corporation or to the extent that such matter relates to service with respect to an employee benefit plan, in the best interests of the participants or beneficiaries of such employee benefit plan. The absence of any express provision for indemnification shall not limit any right of indemnification existing independently of this section. A corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or other agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or other agent of another organization or with respect to any employee benefit plan, against any liability incurred by him in any such capacity, or arising out of his status as such, whether or not the corporation would have the power to indemnify him against such liability." Article XXIX of the By-Laws of the Company provides as follows: ARTICLE XXIX Indemnification of Directors and Others Section 29.1 Definitions For purposes of this Article XXIX: (a) "Director/officer" means any person who is serving or has served as a Director, officer or employee of the Corporation appointed or elected by the Board of Directors or the stockholders of the Corporation, or any Director, officer or employee of the Corporation who is serving or has served at the request of the Corporation as a Director, officer, trustee, principal, partner, member of a committee, employee or other agent of any other organization, - 3 - or in any capacity with respect to any employee benefit plan of the Corporation or any of its subsidiaries. (b) "Proceeding" means any action, suit or proceeding, whether civil, criminal, administrative or investigative, brought or threatened in or before any court, tribunal, administrative or legislative body or agency, and any claim which could be the subject of a Proceeding. (c) "Expense" means any fine or penalty, and any liability fixed by a judgment, order, decree or award in a Proceeding, any amount reasonably paid in settlement of a Proceeding and any professional fees and other disbursements reasonably incurred in connection with a Proceeding. The term "Expense" shall include any taxes or penalties imposed on a Director/officer with respect to any employee benefit plan of the Corporation or any of its subsidiaries. Section 29.2 Right to Indemnification Except as limited by law or as provided in Sections 29.3 and 29.4 of this Article XXIX, each Director/officer (and his heirs and personal representatives) shall be indemnified by the Corporation against any Expense incurred by him in connection with each Proceeding in which he is involved as a result of his serving or having served as a Director/officer. Section 29.3 Indemnification not Available No indemnification shall be provided to a Director/officer with respect to a Proceeding as to which it shall have been adjudicated that he did not act in good faith in the reasonable belief that his action was in the best interests of the Corporation, or, to the extent that such Proceeding relates to service with respect to an employee benefit plan, in the best interests of the participants or beneficiaries of such employee benefit plan. Section 29.4 Compromise or Settlement In the event that a Proceeding is compromised or settled so as to impose any liability or obligation on a Director/officer or upon the Corporation, no indemnification shall be provided as to said Director/officer with respect to such Proceeding if such Director/officer shall have been adjudicated not to have acted in good faith in the reasonable belief that his action was in the best interests of the Corporation, or, to the extent that such Proceeding relates to service with respect to an employee benefit plan, in the best interests of the participants or beneficiaries of such employee benefit plan. Section 29.5 Advances The Corporation shall pay sums on account of indemnification in advance of a final disposition of a Proceeding upon receipt of an undertaking by the Director/officer to repay such sums if it is subsequently established that he is not entitled to indemnification pursuant to Sections 29.3 and 29.4 hereof, which undertaking may be accepted without reference to the financial ability of such person to make repayment. Section 29.6 Not Exclusive Nothing in this Article XXIX shall limit any lawful rights to indemnification existing independently of this Article 29. - 4 - Section 29.7 Insurance The provisions of this Article XXIX shall not limit the power of the Board of Directors to authorize the purchase and maintenance of insurance on behalf of any Director/officer against any liability incurred by him in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under this Article XXIX. Item 7. Exemption from Registration Claimed Inapplicable Item 8. Exhibits NumberDescription 4A Haemonetics Corporation 1998 Employee Stock Purchase Plan 5 Opinion of Hutchins, Wheeler & Dittmar, a Professional Corporation, as to legality of shares being registered and consent. 23 Consents of Experts - included in Registration Statement under heading "Consent of Independent Public Accountants." Item 9. Undertakings The undersigned Registrant hereby undertakes the following: (a) The undersigned Registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement; (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in - 5 - periodic reports filed by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement. (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. (b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (c) The undersigned registrant hereby undertakes, that, insofar as indemnification for liabilities arising under The Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. - 6 - SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Braintree, Massachusetts on August 11, 1998. HAEMONETICS CORPORATION By s/ James L. Peterson James L. Peterson President Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. Title Date s/ Sir Stuart Burgess Chairman of the Board of 8/11/98 Sir Stuart Burgess Directors s/ James L. Peterson President, Chief Executive 8/11/98 James L. Peterson Officer, Director s/ Ronald J. Ryan Senior Vice President of Finance 8/11/98 Ronald J. Ryan and Chief Financial Officer (Principal Financial and Accounting Officer) s/ Yutaka Sakurada Senior Vice President - 8/11/98 - --------------------------------- Yutaka Sakurada Haemonetics Corp., and President - Haemonetics Japan, Director s/ Benjamin L. Holmes Director 8/11/98 Benjamin L. Holmes
- 7 - CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS As independent public accountants, we hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 23, 1998 included in Haemonetics Corporation's Form 10-K for the year ended March 28, 1998 and to all references to our Firm included in this Registration Statement. ARTHUR ANDERSEN LLP /s/Arthur Andersen LLP Boston, Massachusetts, August 7, 1998 320904-1 - 8 -

                             HAEMONETICS CORPORATION
                        1998 Employee Stock Purchase Plan

1.      Purpose
        It is the purpose of this 1998 Employee Stock Purchase Plan to provide a
means  whereby  eligible  employees  may purchase  Common  Stock of  Haemonetics
Corporation  (the  "Company")  through  payroll  deductions.  It is  intended to
provide a further  incentive for employees to promote the best  interests of the
Company and to  encourage  stock  ownership  by employees in order that they may
participate in the Company's economic growth.
        It is the intention of the Company that the Plan qualify as an 
"employee stock purchase plan" within the meaning of Section 423 of the 
Internal Revenue Code and the provisions of this Plan shall be construed in a 
manner consistent with the Code.

2.      Definitions
                The following words or terms,  when used herein,  shall have the
following respective meanings:
        (a)     "Plan" shall mean the 1998 Employee Stock Purchase Plan.
        (b)     "Company" shall mean Haemonetics Corporation, a Massachusetts 
                corporation.
        (c)     "Account" means the Employee Stock Purchase Account established 
                for a Participant under Section 7 hereunder.
        (d)     "Basic  Compensation"  shall mean the regular  rate of salary or
                wages  in  effect   immediately  prior  to  a  Purchase  Period,
                including   sales   commissions,   before  any   deductions   or
                withholdings,  but shall exclude  overtime,  bonuses and amounts
                paid in reimbursement for expenses.

                                      - 1 -





        (e)     "Board of Directors" shall mean the Board of Directors of 
                Haemonetics Corporation.
        (f)     "Code" shall mean the Internal Revenue Code of 1986, as amended.
        (g)     "Committee" shall mean the Stock Purchase Plan Committee 
                appointed and acting in accordance with the terms of the Plan.
        (h)     "Common Stock" shall mean shares of the Company's common stock
                with a par value of $.01 per share.
        (i)     "Effective Date" shall mean May 1, 1998.
        (j)     "Eligible Employees" shall mean all persons employed by the 
                Company or one of its subsidiaries as defined in Section 424 
                of the Code, but excluding:
                (1)      Persons who have been employed by the Company or its 
                         subsidiaries for less than six months on the first day 
                         of the Purchase Period with the
                         exception of persons previously eligible;
                (2)      Persons whose customary employment is less than twenty 
                         hours per week or five months or less per year; and
                (3)      Persons   who  are  deemed  for   purposes  of  Section
                         423(b)(3)  of the Code to own  stock  possessing  5% or
                         more of the total combined voting power or value of all
                         classes  of  stock  of the  Company,  its  parent  or a
                         subsidiary.
        For  purposes  of the Plan,  employment  will be treated  as  continuing
intact while a Participant is on military leave,  sick leave, or other bona fide
leave of  absence,  for up to 90 days or so long as the  Participant's  right to
re-employment is guaranteed either by statute or by contract,  if longer than 90
days.

                                      - 2 -





        (k)     "Exercise  Date"  shall mean the last day of a Purchase  Period;
                provided,  however,  that if such  date is not a  business  day,
                "Exercise  Date" shall mean the immediately  preceding  business
                day.
        (1)     "Participant"  shall  mean an  Eligible  Employee  who elects to
                participate in the Plan under Section 6 hereunder.
        (m)     Except as provided below,  there shall be two "Purchase Periods"
                in each full  calendar  year during which the Plan is in effect,
                one  commencing  on  November  1st of  each  calendar  year  and
                continuing  through  April  30 of such  calendar  year,  and the
                second   commencing  on  May  1st  of  each  calendar  year  and
                continuing through October 31st of such calendar year. The first
                Purchase  Period  after  adoption of the Plan shall  commence on
                November 1, 1998. The last Purchase Period shall commence on May
                1, 2008 and end on October 31, 2008.
        (n)     "Purchase Price" shall mean the lower of (i) 85% of the fair 
                market value of a share of Common Stock for the first business 
                day of the relevant Purchase Period, or (ii) 85% of such value 
                on the relevant Exercise Date.  If the shares of Common Stock
                are listed on any national securities exchange, or traded on 
                the National Association of Securities Dealers Automated 
                Quotation System ("NASDAQ") National Market System, the fair 
                market value per share of Common Stock on a particular day 
                shall be the closing price, if any, on the largest such 
                exchange, or if not traded on an exchange, the NASDAQ National 
                Market System, on such day, and, if there are no sales of the 
                shares of Common Stock on such particular day, the fair market 
                value of a share of Common Stock shall be determined by taking 
                a weighted average of the means between the highest and lowest 
                sales on the nearest date before and the

                                      - 3 -





                nearest  date  after  the  particular  day  in  accordance  with
                Treasury Regulations Section 25.2512-2.  If the shares of Common
                Stock are not then  listed on any such  exchange  or the  NASDAQ
                National  Market  System,  the fair  market  value  per share of
                Common Stock on a  particular  day shall be the mean between the
                closing  "Bid"  and the  closing  "Asked"  prices,  if  any,  as
                reported in the National Daily  Quotation  Service for such day.
                If  the  fair  market  value  cannot  be  determined  under  the
                preceding sentences, it shall be determined in good faith by the
                Board of Directors.

3.      Grant of Option to Purchase Shares.
        Each Eligible Employee shall be granted an option effective on the first
day of each Purchase Period to purchase shares of Common Stock.  The term of the
option shall be the length of the Purchase Period.  The number of shares subject
to each option shall be the quotient of the aggregate payroll  deductions in the
Purchase  Period  authorized by each  Participant  in accordance  with Section 6
divided  by the  Purchase  Price,  but in no event  greater  than 800 shares per
option.  Notwithstanding  the  foregoing,  (i) no  employee  shall be granted an
option which  permits his right to purchase  shares under the Plan and under all
other Code Section  423(b)  employee  stock purchase plans of the Company or any
parent or  subsidiary  corporation  to accrue at a rate which exceeds in any one
calendar  year  $25,000 of the fair market  value of the Common  Stock as of the
date the option to purchase is granted. 4. Shares.
        There shall be 375,000  shares of Common Stock  reserved for issuance to
and purchase by  Participants  under the Plan,  subject to  adjustment as herein
provided.  The shares of Common Stock subject to the Plan shall be either shares
of authorized but unissued Common Stock or shares of Common Stock  reacquired by
the Company and held as treasury shares. Shares of

                                      - 4 -





Common Stock not purchased under an option terminated pursuant to the provisions
of the Plan may again be subject to options granted under the Plan.
        The  aggregate  number of shares of Common  Stock which may be purchased
pursuant  to options  granted  hereunder,  the number of shares of Common  Stock
covered by each  outstanding  option,  the maximum  number of shares that may be
granted in any Purchase Period and the purchase price for each such option shall
be  appropriately  adjusted  for any  increase  or  decrease  in the  number  of
outstanding  shares  of  Common  Stock  resulting  from a stock  split  or other
subdivision  or  consolidation  of shares of Common  Stock or for other  capital
adjustments or payments of stock dividends or  distributions  or other increases
or decreases in the outstanding  shares of Common Stock effected without receipt
of consideration by the Company.
5.      Administration.
        The Plan  shall be  administered  by the Board of  Directors  or a Stock
Purchase Plan  Committee  appointed from time to time by the Board of Directors.
All members of the Committee  shall serve at the  discretion  of the Board.  The
Board of Directors or the Committee,  if one has been appointed,  is vested with
full  authority to make,  administer  and  interpret  such  equitable  rules and
regulations  regarding  the  Plan  as  it  may  deem  advisable.  The  Board  of
Directors', or the Committee's, if one has been appointed,  determinations as to
the interpretation  and operation of the Plan shall be final and conclusive.  No
member of the Board of Directors or the Committee shall be liable for any action
or  determination  made in good  faith  with  respect  to the Plan or any option
granted under the Plan. 6. Election to Participate.
        An Eligible Employee may elect to become a Participant in the Plan for a
Purchase  Period by completing a "Stock  Purchase  Agreement"  form prior to the
first day of the Purchase Period

                                      - 5 -





for which the election is made.  Such Stock Purchase  Agreement shall be in such
form as shall be  determined  by the Board of  Directors or the  Committee.  The
election to participate  shall be effective for the Purchase Period for which it
is made.  There is no limit on the  number  of  Purchase  Periods  for  which an
Eligible  Employee may elect to become a  Participant  in the Plan. In the Stock
Purchase  Agreement,  the Eligible  Employee  shall  authorize  regular  payroll
deductions  of any full  percentage of his Basic  Compensation,  but in no event
less  than  two  percent  nor  more  than  eight   percent  (8%)  of  his  Basic
Compensation.  An Eligible Employee may not change his  authorization  except as
otherwise  provided in Section 9. Options granted to Eligible Employees who have
failed to execute a Stock Purchase  Agreement within the time periods prescribed
by the Plan will automatically lapse. 7. Employee Stock Purchase Account.
        An  Employee  Stock  Purchase  Account  will  be  established  for  each
Participant in the Plan for bookkeeping  purposes,  and payroll  deductions made
under  Section  6 will be  credited  to such  Accounts.  However,  prior  to the
purchase  of  shares  in  accordance  with  Section  8  or  withdrawal  from  or
termination of the Plan in accordance  with the provisions  hereof,  the Company
may  use  for  any  valid  corporate   purpose  all  amounts   deducted  from  a
Participant's wages under the Plan and credited for bookkeeping  purposes to his
Account.
        The  Company  shall be  under no  obligation  to pay  interest  on funds
credited  to a  Participant's  Account,  whether  upon  purchase  of  shares  in
accordance  with Section 8 or upon  distribution in the event of withdrawal from
or termination of the Plan as herein provided.
8.      Purchase of Shares.
        Each Eligible  Employee who is a Participant  in the Plan  automatically
and without any act on his part will be deemed to have  exercised  his option on
each Exercise Date to the extent that

                                      - 6 -





the balance then in his Account  under the Plan is sufficient to purchase at the
Purchase  Price whole  shares of the Common  Stock  subject to his  option.  Any
balance  remaining in the  Participant's  Account  shall be carried  forward and
credited for use in the next  Purchase  Period.  If the Employee  chooses not to
participate in the next Purchase Period,  any balance will be refunded to him in
cash.  Notwithstanding  the foregoing,  any balance remaining in a Participant's
Account  at the end of a  Purchase  Period  as a  result  of  aggregate  payroll
deductions  having  exceeded  the  limitations  set forth in  Section 3 shall be
refunded to the Participant in cash without interest. 9. Withdrawal.
        A Participant  who has elected to authorize  payroll  deductions for the
purchase of shares of Common Stock may cancel his election by written  notice of
cancellation  delivered  to the office or person  designated  by the  Company to
receive  Stock  Purchase  Agreements  ("Cancellation"),  but any such  notice of
Cancellation  must be so  delivered  not  later  than ten (10) days  before  the
relevant Exercise Date.
        A  Participant  will  receive  in  cash,  as soon as  practicable  after
delivery of the notice of Cancellation,  the amount credited to his Account. Any
Participant who so withdraws from the Plan may again become a Participant at the
start of the next Purchase Period in accordance with Section 6.
        Upon   dissolution  or  liquidation  of  the  Company  or  a  merger  or
consolidation  in which the Company is not the  surviving  entity  every  option
outstanding hereunder shall terminate,  in which event each Participant shall be
refunded the amount of cash then in his Account.
10.     Issuance of Stock Certificates.

                                      - 7 -





        The shares of Common Stock  purchased by a  Participant  shall,  for all
purposes, be deemed to have been issued and sold at the close of business on the
Exercise  Date.  Prior  to that  date  none of the  rights  or  privileges  of a
stockholder  of the Company,  including the right to vote or receive  dividends,
shall exist with respect to such shares.
        Within a reasonable  time after the  Exercise  Date,  the Company  shall
issue  and  deliver a  certificate  for the  number  of  shares of Common  Stock
purchased by a Participant for the Purchase Period,  which  certificate shall be
registered  either  in the  Participant's  name,  jointly  in the  names  of the
Participant  and his spouse,  or in the name of the Participant or his spouse as
guardian for their  children,  as the  Participant  shall designate in his Stock
Purchase Agreement. Such designation may be changed at any time by filing notice
thereof with the party  designated by the Company to receive such  notices.  11.
Termination of Employment.
        (a)     Upon a  Participant's  termination of employment for any reason,
                other  than  death,  no payroll  deduction  may be made from any
                compensation  due him and the  entire  balance  credited  to his
                Account shall be automatically refunded.
        (b)     Upon the death of a Participant,  no payroll  deduction shall be
                made from any  compensation  due him at time of  death,  and the
                entire  balance in the deceased  Participant's  Account shall be
                paid in cash to the  Participant's  designated  beneficiary,  if
                any, under a group  insurance plan of the Company  covering such
                employee, or otherwise to his estate.
12.     Rights Not Transferable.
        The  right to  purchase  shares  of  Common  Stock  under  this  Plan is
exercisable only by the Participant  during his lifetime and is not transferable
by him. If a Participant attempts to transfer

                                      - 8 -





his  right to  purchase  shares  under  the  Plan,  he shall be  deemed  to have
requested  withdrawal from the Plan and the provisions of Section 9 hereof shall
apply with respect to such Participant.
13.     No Guarantee of Continued Employment.
        Granting of an option  under this Plan shall imply no right of continued
employment with the Company for any Eligible Employee.
14.     Notice.
        Any notice which an Eligible  Employee or Participant  files pursuant to
this Plan  shall be in  writing  and shall be  delivered  personally  or by mail
addressed to Haemonetics  Corporation,  400 Wood Road, Braintree,  Massachusetts
02184 Attn: Alicia R. Lopez,  General Counsel. Any notice to a Participant or an
Eligible  Employee  shall be  conspicuously  posted in the  Company's  principal
office or shall be mailed  addressed to the Participant or Eligible  Employee at
the  address  designated  in the Stock  Purchase  Agreement  or in a  subsequent
writing.
15.     Application of Funds.
        All funds  deducted  from a  Participant's  wages in payment  for shares
purchased or to be purchased under this Plan may be used for any valid corporate
purpose  provided  that the  Participant's  Account  shall be credited  with the
amount of all  payroll  deductions  as  provided  in Section  7. 16.  Government
Approvals or Consents.
        This Plan and any offering and sales to Eligible  Employees under it are
subject  to any  governmental  approvals  or  consents  that  may  be or  become
applicable in connection therewith. Subject to the provisions of Section 17, the
Board of  Directors of the Company may make such changes in the Plan and include
such terms in any offering under this Plan as may be necessary

                                      - 9 -





or desirable, in the opinion of counsel, to comply with the rules or regulations
of any governmental authority, or to be eligible for tax benefits under the Code
or the laws of any state.
17.     Amendment of the Plan.
        The Board of  Directors  may,  without the consent of the  Participants,
amend the Plan at any time,  provided that no such action shall adversely affect
options theretofore  granted hereunder,  and provided that no such action by the
Board of  Directors  without  approval of the  Company's  stockholders  may: (a)
increase  the total  number of shares of Common  Stock which may be purchased by
all  Participants;  or (b) change  the class of  employees  eligible  to receive
options under the Plan.
        For purposes of this Section 17, termination of the Plan by the Board of
Directors  pursuant  to  Section  18 shall not be  deemed to be an action  which
adversely affects options theretofore granted hereunder.
        18.     Term of the Plan.
        The Plan shall become effective on the Effective Date,  provided that it
is approved  within twelve months after  adoption by the Board of Directors at a
duly-held  stockholder's  meeting  by  stockholders  of the  Company  holding  a
majority  of the  Company's  voting  stock.  The Plan shall  continue  in effect
through October 31, 2008, provided,  however,  that the Board of Directors shall
have the right to terminate the Plan at any time. In the event of the expiration
of the Plan or its  termination,  all options  then  outstanding  under the Plan
shall  automatically  be cancelled and the entire amount credited to the Account
of each Participant hereunder shall be refunded to each such Participant.

                                     - 10 -





        19.     Withholding of Additional Income Taxes.
        By electing to participate in the Plan,  each  Participant  acknowledges
that the  Company is  required  to  withhold  taxes with  respect to the amounts
deducted from the Participant's  compensation and accumulated for the benefit of
the Participant under the Plan and each Participant  agrees that the Company may
deduct additional amounts from the Participant's compensation,  when amounts are
added to the Participant's  account,  used to purchase Common Stock or refunded,
in order to satisfy  such  withholding  obligations.  Each  Participant  further
acknowledges that when Common Stock is purchased under the Plan, the Company may
be required to withhold taxes with respect to all or a portion of the difference
between the fair market  value of the Common  Stock  purchased  and its purchase
price,  and each  Participant  agrees  that  such  taxes  may be  withheld  from
compensation  otherwise  payable to such  Participant.  It is intended  that tax
withholding  will be  accomplished  in such a manner  that the  full  amount  of
payroll  deductions  elected by the Participant  under Section 6 will be used to
purchase Common Stock.  However, if amounts sufficient to satisfy applicable tax
withholding  obligations  have not been  withheld  from  compensation  otherwise
payable to any  Participant,  then,  notwithstanding  any other provision of the
Plan,  the Company may withhold  such taxes from the  Participant's  accumulated
payroll  deductions  and apply the net amount to the  purchase of Common  Stock,
unless the  Participant  pays to the  Company,  prior to the exercise  date,  an
amount  sufficient to satisfy such  withholding  obligations.  Each  Participant
further  acknowledges  that the Company  may be  required  to withhold  taxes in
connection with the disposition of stock acquired under the Plan and agrees that
the Company may take whatever  action it considers  appropriate  to satisfy such
withholding  requirements,   including  deducting  from  compensation  otherwise
payable to such  Participant  an amount  sufficient to satisfy such  withholding
requirements or conditioning

                                     - 11 -




any  disposition  of Common  Stock by the  Participant  upon the  payment to the
Company of an amount sufficient to satisfy such withholding requirements.
20.     General.
        Whenever the context of this Plan permits,  the  masculine  gender shall
include the feminine and neuter genders.

295742-1

                                     - 12 -




                                                          August 11, 1998


Haemonetics Corporation
400 Wood Road
Braintree, MA 02184

Ladies and Gentlemen:

         We are counsel to Haemonetics Corporation,  a Massachusetts Corporation
(the  "Company"),  and as  such  counsel  we are  familiar  with  the  corporate
proceedings taken in connection with the adoption of the Company's 1998 Employee
Stock  Purchase  Plan (the "Plan").  We are also familiar with the  Registration
Statement  on Form S-8 to which a copy of this  opinion  will be  attached as an
exhibit.

         As such counsel,  we have examined the corporate records of the Company
including its Restated Articles of Organization, as amended, By-laws, Minutes of
Meetings of its Board of Directors and  Stockholders and such other documents as
we have deemed necessary as a basis for the opinions herein expressed.

         Based  upon  the  foregoing,   and  having  regarding  for  such  legal
considerations as we deem relevant, we are of the opinion that:

         1.       The Company is validly existing as a corporation and in good 
corporate standing under the laws of the Commonwealth of Massachusetts.

         2.       The Company has duly authorized the issuance of 80,000,000 
shares of common stock, $.01 par value per share ("Common Stock").

         3. The shares of Common Stock  issuable  pursuant to the Plan have been
duly authorized,  and when issued in accordance with the terms of the Plan, such
shares will be validly issued,  fully paid and  nonassessable  shares of capital
stock of the Company to which no personal liability will attach.

         We hereby  consent to the  filing of this  opinion as an exhibit to the
Registration  Statement  on Form S-8 and to  reference  to us under the  caption
"Interest of Named Experts and Counsel" in the Registration Statement.

                                     Very truly yours,

                                     /s/Hutchins, Wheeler & Dittmar
 
                                     Hutchins, Wheeler & Dittmar
                                     A Professional Corporation

MEO:smt:335354-1